Sailong Pharmaceutical Group Co.,Ltd. (SHE:002898)

China · Delayed Price · Currency is CNY

0.3700

-0.0100 (-2.63%)

Inactive · Last trade price on Jul 16, 2026

-97.23% (1Y)

Market Cap	65.12M -94.3%
Revenue (ttm)	618.17M +149.1%
Net Income	-129.12M
EPS	-0.73
Shares Out	176.00M
PE Ratio	n/a
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	9,912,194
Open	0.3800
Previous Close	0.3800
Day's Range	0.3700 - 0.3900
52-Week Range	0.3000 - 17.4900
Beta	0.07
Analysts	n/a
Price Target	n/a
Earnings Date	Aug 20, 2026

About SHE:002898

Sailong Pharmaceutical Group Co.,Ltd. researches, develops, produces, markets, and services pharmaceutical intermediates, raw materials, and preparations in China. The company offers esomeprazole sodium, ornithine aspartate, thymus, argatroban, tigecycline, monosialotetrahexose ganglioside sodium, cerebroprotein hydrolysate, milrinone, parecoxib sodium, tranexamic acid, clindamycin phosphate, pantoprazole sodium products, etc. It provides its products for therapeutic areas, such as cardiovascular, cerebrovascular, nerve, digestive system, proto... [Read more]

Industry Biotechnology

Sector Healthcare

Founded 2002

Employees 418

Stock Exchange Shenzhen Stock Exchange

Ticker Symbol 002898

Full Company Profile

Financial Performance

In 2025, SHE:002898's revenue was 518.76 million, an increase of 96.82% compared to the previous year's 263.57 million. Losses were -121.17 million, 265.6% more than in 2024.

Financial Statements